title: Role of Alendronate in Managing Osteoporosis in Celiac Disease - Illustrative Case Report.
abstract: Management of bone density loss, as the result of calcium malabsorption in celiac disease, is critical in preventing premature bone fracture. As many of these patients need follow-up with primary care providers, internists are expected to be aware of screening and prompt management of osteopenia or osteoporosis in celiac disease. We present a case of a 32-year-old man with celiac disease who was diagnosed with osteoporosis. He was treated with calcium, vitamin D and alendronate which improved bone mineral density. This case illustrates the importance of using bisphosphonate in treating osteoporosis in celiac disease.
authors.affiliation: Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
authors.forename: David
authors.initials: D
authors.lastname: Widjaja
authors.affiliation: Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
authors.forename: Kalyan C
authors.initials: KC
authors.lastname: Kanneganti
authors.affiliation: Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
authors.forename: Madanmohan
authors.initials: M
authors.lastname: Patel
authors.affiliation: Department of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
authors.forename: Sridhar S
authors.initials: SS
authors.lastname: Chilimuri
keywords: Alendronate; Celiac disease; Osteoporosis